Devloping Biomarkers to Inform PK/PD & Patient Populations in Clinical Trials

Time: 8:30 am
day: Conference Day Two


  • In vitro and in vivo models to inform biomarker development in the clinic
  • Identifying biomarkers to elucidate complement therapeutic MOA and PD effects in clinical trials
  • Identifying the most useful patient population to see efficacy in trial